Arkolith/Insider Trading/STSA/Form 4

Shin Nippon Biomedical Laboratories, Ltd.

10% OwnerSatsuma Pharmaceuticals, Inc. (STSA) · full profile →Form 4 · filed Jun 8, 2023
Net Buying
Open-Market Buys
$27.7M
Open-Market Sells
$0
Net Open-Market Flow
$27.7M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2023Buy(P)8.4M$0.91$7.7M8.4M
Jun 6, 2023Buy(P)22.1M$0.91$20.1M22.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-014866) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML